95 related articles for article (PubMed ID: 28606429)
1. Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis.
Celestino Pinto L; de Fátima Aquino Moreira-Nunes C; Soares BM; Burbano RMR; de Lemos JAR; Montenegro RC
Toxicol In Vitro; 2017 Sep; 43():87-91. PubMed ID: 28606429
[TBL] [Abstract][Full Text] [Related]
2. Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01).
Pinto LC; Mesquita FP; Soares BM; da Silva EL; Puty B; de Oliveira EHC; Burbano RR; Montenegro RC
Toxicol In Vitro; 2019 Oct; 60():305-312. PubMed ID: 31207347
[TBL] [Abstract][Full Text] [Related]
3. The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model.
Pinto LC; Soares BM; Pinheiro Jde J; Riggins GJ; Assumpção PP; Burbano RM; Montenegro RC
Toxicol In Vitro; 2015 Dec; 29(8):2038-44. PubMed ID: 26315676
[TBL] [Abstract][Full Text] [Related]
4. EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH.
Sawanyawisuth K; Williamson T; Wongkham S; Riggins GJ
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1264-70. PubMed ID: 26466412
[TBL] [Abstract][Full Text] [Related]
5. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
Blom K; Senkowski W; Jarvius M; Berglund M; Rubin J; Lenhammar L; Parrow V; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):199-210. PubMed ID: 28472897
[TBL] [Abstract][Full Text] [Related]
6. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
Nygren P; Fryknäs M; Agerup B; Larsson R
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiparasitic activity of albendazole and mebendazole analogues.
Navarrete-Vázquez G; Yépez L; Hernández-Campos A; Tapia A; Hernández-Luis F; Cedillo R; González J; Martínez-Fernández A; Martínez-Grueiro M; Castillo R
Bioorg Med Chem; 2003 Oct; 11(21):4615-22. PubMed ID: 14527558
[TBL] [Abstract][Full Text] [Related]
8. XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts.
Doudican NA; Byron SA; Pollock PM; Orlow SJ
Anticancer Drugs; 2013 Feb; 24(2):181-8. PubMed ID: 23059386
[TBL] [Abstract][Full Text] [Related]
9. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning.
Aliabadi A; Haghshenas MR; Kiani R; Koohi-Hosseinabadi O; Purkhosrow A; Pirsalami F; Panjehshahin MR; Erfani N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2379-2388. PubMed ID: 37837472
[TBL] [Abstract][Full Text] [Related]
11. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
Ohbatake Y; Fushida S; Tsukada T; Kinoshita J; Oyama K; Hayashi H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Yashiro M; Hirakawa K; Ohta T
Clin Exp Med; 2016 Nov; 16(4):585-592. PubMed ID: 26359244
[TBL] [Abstract][Full Text] [Related]
12. Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death.
da Silva EL; Mesquita FP; Aragão DR; de Sousa Portilho AJ; Marinho AD; de Oliveira LLB; Lima LB; de Moraes MEA; Souza PFN; Montenegro RC
Toxicol Appl Pharmacol; 2023 Sep; 475():116630. PubMed ID: 37473966
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway.
Mizuno K; Toyoda Y; Fukami T; Nakajima M; Yokoi T
Arch Toxicol; 2011 Mar; 85(3):199-207. PubMed ID: 20848085
[TBL] [Abstract][Full Text] [Related]
14. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
[TBL] [Abstract][Full Text] [Related]
15. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness.
Joe NS; Godet I; Milki N; Ain NUI; Oza HH; Riggins GJ; Gilkes DM
Breast Cancer Res; 2022 Dec; 24(1):98. PubMed ID: 36578038
[TBL] [Abstract][Full Text] [Related]
16. An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.
Liu CS; Zhang HB; Lei W; Zhang CW; Jiang B; Zheng Q; Yin JH; Han XM
Parasit Vectors; 2014 Dec; 7():589. PubMed ID: 25491386
[TBL] [Abstract][Full Text] [Related]
17. Residue study of mebendazole and its metabolites hydroxy-mebendazole and amino-mebendazole in eel (Anguilla anguilla) after bath treatment.
Iosifidou EG; Haagsma N; Olling M; Boon JH; Tanck MW
Drug Metab Dispos; 1997 Mar; 25(3):317-20. PubMed ID: 9172949
[TBL] [Abstract][Full Text] [Related]
18. [Long term eradication rate of mebendazole therapy for strongyloidiasis].
Shikiya K; Zaha O; Niimura S; Ikema M; Nakamura H; Nakayoshi T; Uechi H; Kinjo F; Saito A; Ohwan T
Kansenshogaku Zasshi; 1992 Mar; 66(3):354-9. PubMed ID: 1624824
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers.
Sakakura C; Hagiwara A; Fukuda K; Shimomura K; Takagi T; Kin S; Nakase Y; Fujiyama J; Mikoshiba K; Okazaki Y; Yamagishi H
Anticancer Res; 2003; 23(5A):3691-7. PubMed ID: 14666665
[TBL] [Abstract][Full Text] [Related]
20. Mebendazole preferentially inhibits cilia formation and exerts anticancer activity by synergistically augmenting DNA damage.
Hong J; Kwon KY; Jang DG; Kwon T; Yoon H; Park TJ
Biomed Pharmacother; 2024 May; 174():116434. PubMed ID: 38513592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
